Three-month <i>ad interim</i> analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster.

Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe

Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster.

Salvagno, Gian Luca; Henry, Brandon M; Pighi, Laura; De Nitto, Simone; Gianfilippi, Gianluca; Lippi, Giuseppe.

Salvagno GL; Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Henry BM; Service of Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy.
Pighi L; Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
De Nitto S; Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Gianfilippi G; Service of Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy.
Lippi G; Section of Clinical Biochemistry, University of Verona, Verona, Italy.

Clin Chem Lab Med ; 60(8): e181-e183, 2022 07 26.

Article in English | MEDLINE | ID: covidwho-1846970

Subject(s)

COVID-19; Vaccines; Antibodies, Viral; BNT162 Vaccine; COVID-19/prevention & control; Humans

Keywords

COVID-19; SARS-CoV-2; antibodies; immune response; vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Clin Chem Lab Med Journal subject: Chemistry, Clinical / Laboratory Techniques and procedures Year: 2022 Document Type: Article Affiliation country: Cclm-2022-0385

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google